Home » Newsletters » BioWorld Asia

BioWorld Asia

June 20, 2001

View Archived Issues

MelTec, Evotec Form Venture For Drug Discovery, Services

Heat-Shock Proteins Suggest New Mode Of Attack On TB

Cyclacel Raises $47.7M For Cell-Cycle Cancer Programs

Meristem Enters Cystic Fibrosis Licensing Agreement With Solvay

Ethypharm Sets Target Of $137M For IPO in France

Parliament Genetics Debate Takes Pro-Industry Direction

Galapagos, Bayer Enter Deal To Discover Protein Functions

Association Seeks More Options For Biotechnology Product Filings

Other News To Note

DeCODE Enters Monoclonal Antibody Deal With Genmab

Zentaris Cites Market Conditions In Postponing IPO In Germany

Oxford Glyco, Marconi Create Venture For Protein Databases

Amaxas Second Round Nets EUR13M For Transfection Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.